| Literature DB >> 31687975 |
Christopher D Wiley1, Alexis N Brumwell2, Sonnet S Davis1, Julia R Jackson2, Alexis Valdovinos1, Cheresa Calhoun3, Fatouma Alimirah1, Carlos A Castellanos2, Richard Ruan2, Ying Wei2, Harold A Chapman2, Arvind Ramanathan1,4, Judith Campisi1,5, Claude Jourdan Le Saux2,3.
Abstract
Accumulation of senescent cells is associated with the progression of pulmonary fibrosis, but mechanisms accounting for this linkage are not well understood. To explore this issue, we investigated whether a class of biologically active profibrotic lipids, the leukotrienes (LT), is part of the senescence-associated secretory phenotype. The analysis of conditioned medium (CM), lipid extracts, and gene expression of LT biosynthesis enzymes revealed that senescent cells secreted LT, regardless of the origin of the cells or the modality of senescence induction. The synthesis of LT was biphasic and followed by antifibrotic prostaglandin (PG) secretion. The LT-rich CM of senescent lung fibroblasts (IMR-90) induced profibrotic signaling in naive fibroblasts, which were abrogated by inhibitors of ALOX5, the principal enzyme in LT biosynthesis. The bleomycin-induced expression of genes encoding LT and PG synthases, level of cysteinyl LT in the bronchoalveolar lavage, and overall fibrosis were reduced upon senescent cell removal either in a genetic mouse model or after senolytic treatment. Quantification of ALOX5+ cells in lung explants obtained from idiopathic pulmonary fibrosis (IPF) patients indicated that half of these cells were also senescent (p16Ink4a+). Unlike human fibroblasts from unused donor lungs made senescent by irradiation, senescent IPF fibroblasts secreted LTs but failed to synthesize PGs. This study demonstrates for the first time to our knowledge that senescent cells secrete functional LTs, significantly contributing to the LT pool known to cause or exacerbate IPF.Entities:
Keywords: Cell Biology; Cellular senescence; Eicosanoids; Fibrosis; Pulmonology
Mesh:
Substances:
Year: 2019 PMID: 31687975 PMCID: PMC6975274 DOI: 10.1172/jci.insight.130056
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708